Management Change in Moberg Pharma

STOCKHOLM, April 19th, 2018 -- (Healthcare Sales & Marketing Network) -- Moberg Pharma AB (OMX: MOB) announces that Kjell Rensfeldt, VP Research and Development, will retire in the fall but remain with the company part-time as Senior Adviser. On Octobe... Biopharmaceuticals, Personnel Moberg Pharma
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news